WO2019135220A1 - Dispositif destiné à être déployé et retenu dans deux cavités opposées - Google Patents

Dispositif destiné à être déployé et retenu dans deux cavités opposées Download PDF

Info

Publication number
WO2019135220A1
WO2019135220A1 PCT/IL2019/050004 IL2019050004W WO2019135220A1 WO 2019135220 A1 WO2019135220 A1 WO 2019135220A1 IL 2019050004 W IL2019050004 W IL 2019050004W WO 2019135220 A1 WO2019135220 A1 WO 2019135220A1
Authority
WO
WIPO (PCT)
Prior art keywords
elongated member
cavities
peripheral
deployment
segments
Prior art date
Application number
PCT/IL2019/050004
Other languages
English (en)
Inventor
Guy Soffer
Original Assignee
Guy Soffer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guy Soffer filed Critical Guy Soffer
Priority to CN201980014963.8A priority Critical patent/CN111867533B/zh
Priority to EP19702311.2A priority patent/EP3735210A1/fr
Priority to AU2019205139A priority patent/AU2019205139A1/en
Priority to US15/733,338 priority patent/US11826233B2/en
Priority to CA3085372A priority patent/CA3085372A1/fr
Publication of WO2019135220A1 publication Critical patent/WO2019135220A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
    • A61F11/20—Ear surgery
    • A61F11/202—Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0272—Electro-active or magneto-active materials
    • A61M2205/0288—Electro-rheological or magneto-rheological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0272—Electro-active or magneto-active materials
    • A61M2205/0294—Piezoelectric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A61M2205/584—Means for facilitating use, e.g. by people with impaired vision by visual feedback having a color code
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/587—Lighting arrangements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0662—Ears
    • A61M2210/0675—Eustachian tube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1425—Uterine tubes

Definitions

  • the present disclosure relates to a medical device, more specifically a device deployable in an anatomical cavity.
  • Otitis media is a group of inflammatory diseases of the middle ear and one of the most common diagnosed sickness in children.
  • One of the main causes of Otitis media is a dysfunction of the Eustachian tube, namely a blockage or stenosis thereof.
  • the Eustachian tube links the nasopharynx to the middle ear and is part of the latter.
  • the Eustachian tube is the only link of the middle ear to the outside atmosphere.
  • the Eustachian tube is in a collapsed state, not permitting air flow between the middle ear and the nasopharynx but upon the need of equilibration of pressure, for example when there is an ambient pressure change, the Eustachian tube is openable by swallowing or by induced positive pressure from the middle ear towards the nasopharynx.
  • ETD Eustachian tube disorder
  • the present disclosure provides a medical device with portions that are configured for fitting and being retained simultaneously into two cavities on opposite sides of the body of a subject, and in some specific embodiments two sides of the skull.
  • two sides of the body it means the two sides with respect to a symmetrical axis of the body.
  • the subject may be a human subject or a non-human animal.
  • the device may comprise an elongated member with a central segment and first and second peripheral segments extending therefrom.
  • These segments differ in their intended function and eventual in situ positioning: the two peripheral segments intended for insertion and positioning within the two cavities and exerting their function within the cavities.
  • the central segment serves as a link between two peripheral segments and may also be used for some other functions by its position.
  • the elongated member may have elastic properties.
  • these three segments are continuous and not discernible from one another.
  • all three segments may have the same overall configuration with no discernible borders or demarcations between them, the division into segments being only functional in accordance with their intended deployed position.
  • the segments are clearly defined, for example by a different appearance and configuration (e.g. the peripheral segment comprising a helical or stent-like portion) or, for example, may be separated by a functional element, such as an elastic portion.
  • the elongated member is configured to be in physical contact with or in proximity to the soft-pallet, such that movements of the soft- pallet are inducing vibrations or movements of the device.
  • the device is configured to be deployed such that its peripheral segments fit into first and second cavities on opposite sides of a skull of a subject.
  • the two peripheral segments are, typically, but not exclusively, symmetrical with respect to a midline at said central segment.
  • the peripheral segments are adapted for inserting into and to be retained within the cavities.
  • the device has typically at least two configurations - a deployment configuration, assumed prior and during deployment and a deployed configuration in which it is deployed and retained within the cavities. In the deployed configuration, the two peripheral segments are positioned within the opposite cavities of the skull and being integrally linked by the central segment.
  • the device can be configured for deployment in variety of cavities of the skull such as Eustachian tubes, sinuses, nasal cavities. In a more general sense, the device can be deployed in a variety of body cavities. One example is inside the womb while connecting the two fallopian tubes.
  • a device configured for deployment in the Eustachian tubes is a particular embodiment of this disclosure.
  • the device comprises one or more sections made of an elastic or flexible element such as a spring, e.g. in the form of a helical coil.
  • the at least one peripheral segment is configured as or comprises a stent element.
  • the peripheral segment comprises an expansion member configured to expand the cavity while applying pressure onto the cavity walls.
  • the expansion member can be in a form of inflatable/collapsible element such as balloon or in a form of expandable/foldable elements such as wings.
  • the expansion members are actuated through an actuator and can be switched from one state to another.
  • the elongated member is tubular with at least one central port, e.g. at the central segment, and at least two peripheral ports at the peripheral segments.
  • This arrangement permits the delivery of a therapeutic substance introduced through the central port into the cavities, drainage or pumping of liquids or gas into or away from the cavities (e.g. equalizing pressure or pumping gas which may be air, oxygen, nitrogen, carbon dioxide, etc., into the cavity to thereby clearing a blockage).
  • the device has, typically, a deployment state in which it is brought initially into position and a deployed state assumed by it after its deployment in situ.
  • the device is configured to be biased into a deployed state, such that during deployment it is restrained in the deployment state and then released once in position to thereby switch into the deployed state.
  • the switching of the device from a deployment state into a deployed state is by forced manipulation.
  • the device and specifically the elongated member, may be made of biocompatible materials, may be made of metal (e.g. nitinol), plastic material, silicon, etc., or any combination thereof.
  • metal e.g. nitinol
  • plastic material e.g. silicon, etc., or any combination thereof.
  • the device includes at least one vibrations-inducing element, typically associated with the central segment, configured for inducing vibrations onto the elongated member. Vibrations of the elongated member can induce a dilation of the cavity or opening of a blocked or clogged passageway and consequently an expulsion of blocking fluids or solids.
  • the vibrating element comprises a magnet or an electric coil that can be induced to vibrate by an external magnetic field or a piezoelectric member that can be induced to vibrate by an external electric field.
  • the vibrations-inducing element is at least one piezoelectric element, typically associated with the central segment. In some other embodiments, the piezoelectric element is embedded in the elongated member.
  • the device can have at least one sensor for sensing one or more physiological or device-associated parameters.
  • the sensed data can be recorded in a local memory or be transmitted periodically or in real-time (by wireless communication) to an external device using RF, Bluetooth, other low-energy transmitters, etc..
  • the peripheral segments have at least one head unit.
  • the head unit structure can be altered between a deployment and deployed states and can be utilized for anchoring the device in the cavity.
  • the head unit can serve the function of a unidirectional valve intended to permit flow of fluids in the cavity generally in one direction.
  • the elongated member is configured with or comprises stopper elements for preventing the device from sliding too deeply into the cavity.
  • the head unit has a screw like shape and is configured to spin along its longitudinal axis to thereby advance into the cavity in a screw-like manner while at the same time pushing or forcing fluids backwards towards the nasal cavity.
  • the device has at least one weight fixed to or integral with the elongated member.
  • the weight is typically positioned at and associated with the central segment, e.g. about a midline, and is intended to amplify the vibrations and add momentum to the vibrating elongated member.
  • the device can have radio frequency (RF) transducers, typically proximal to one of the ends, to aid tissue recovery.
  • RF radio frequency
  • the elongated member may include markings that are indicative of the length of the elongated member. Namely, by observing a marking, a user of the device can learn about the distance from one end or from a mid- portion to the point of the marking. Thus, when the device is deployed, the marking may indicate the depth of the Eustachian tube.
  • the markings are indicative of the length from a mid-portion of the elongated member towards one or both distal ends thereof.
  • each marking identifies the length of the portion of the elongated member, from its location towards an end or towards a mid-portion of the elongated member, by its color.
  • Figs. 1A-1C, Fig. 2, Fig. 5 and Fig. 6 are schematic illustrations of devices according to embodiments of this disclosure with their two peripheral segments positioned within the Eustachian tubes.
  • Fig. 3 is a schematic illustration of a device according to another embodiment of this disclosure that has an overall tubular structure.
  • Fig. 4 is a schematic illustration of a peripheral segment of a device according to another embodiment of this disclosure within an Eustachian tube that has a head unit that functions as a uni-directional valve intended to permit flow of fluids in the cavity generally in one direction.
  • Fig. 7A-7B are schematic illustrations of a collapsible/expandable structure of the peripheral segment of a device according to another embodiment of this disclosure.
  • Figs. 8A-8B are schematic illustrations of a deployment configuration and a deployed configuration of a device according to another embodiment of the present disclosure.
  • Fig. 9A-9B are schematic illustrations of a device of another embodiment deployed in the Eustachian tubes and confined therein.
  • Fig. 10A-10D are schematic illustrations of a device of an embodiment of this disclosure deployed in Eustachian tubes and showing its lumen dilation effect while vibrating.
  • Fig. 11 is a schematic illustration of a non-limiting example of an embodiment of the device of the present disclosure.
  • Fig. 1A shows device 100 configured as a continuous elongated member 102 with a central segment 103 and two peripheral segments 104, 106 extending therefrom.
  • Device 100 is symmetrical with respect to midline of the body (X axis) and is shown herein in its deployed state with its two peripheral segments 104, 106 positioned within a subject's Eustachian tubes 110 and 108, respectively.
  • elongated member 102 is substantially uniform throughout its length.
  • the elongated member may have integral elasticity-inducing elements, such as element 105 in Figs. IB and 1C, such as a spring, e.g. helical coil, integrally formed within the elongated member.
  • the elastic element may, for example, be a single element formed within the central segment or such elements formed between the central segment and the peripheral segments. Such configurations are schematically shown in Figs. IB and 1C, respectively.
  • the device typically has a deployment state and a deployed state.
  • the device is typically brought into position by a suitably configured applicator (not shown), in a deployment state in which it may be bent, e.g. about a midline, brought into position and then switched into a deployed state with its two end segments deployed in cavities formed at opposite sides of the skull.
  • a suitably configured applicator typically has two guiding ends, each is configured to guide the delivery of the device into a different side of the skull's cavities.
  • the guiding ends accommodate an image acquisition device, e.g. a camera, transmitting the acquired video or image data, through wireless communication, to a receiving system, namely a monitor, that is capable of presenting a real-time video or images received from the camera.
  • the guiding ends also accommodate a light source for lighting at least a portion of the field of view of the camera.
  • Switching between the deployment state and the deployed state may be through an intrinsic bias of the elongated member, in which case the device will be constrained by the applicator in the deployment state, switching spontaneously into the deployed state once the constraint is released. Alternatively, such switching between the two states may be through a forced manipulation. Switching between the deployment state and the deployed state can be achieved, by one embodiment through plastic deformation of the segments of the device.
  • a switching mechanism according to one exemplary embodiment is illustrated schematically in Figs. 8A-8B. Fig.
  • FIG. 8A shows a deployment configuration of a device 800 having a central segment 803 that is divided into two individual sub-segments 803A and 803B which are connected by a wire 840 that is attached or linked to a spring 842, contained within a lumen 843 formed within sub-segment 803B.
  • spring 842 is in a stretched state.
  • Each of sub- segments 803 A, 803B can be deployed into a respective cavity and after being in position, the biasing action of the spring 842 causes the proximal portion 845 of sub-segment 803A to snap into position with the coupling receptacle 844 as seen in Fig. 8B.
  • the applicator is released from the device.
  • the device may then be left in the cavities for a certain amount of time, according to a decision of a practitioner.
  • a removal applicator has two grabbing arms that are configured to be inserted through the nostrils and grab at least a portion of each side of the device for safe removal thereof. Before the removal of the device, it can be cut into two sections such that each section is being held by one grabbing arm.
  • the device may have functional peripheral elements.
  • Fig. 2 showing a schematic illustration of another exemplary, non-limiting embodiment of this disclosure, in which the peripheral segments comprise stent elements 212, 214.
  • the stent has a deployment state where it has a narrow cross-section and then, once in situ , it is extended to assume the deployed state, shown in Fig. 2.
  • the stent elements are fixed or loosely coupled to the peripheral segments via a connecting member (e.g. a wire, suture, etc.) to limit the axial movement along the tube and thereby reduce risk that the stents, coupled to the device, will slide into the nasopharynx.
  • a connecting member e.g. a wire, suture, etc.
  • the elongated member of this embodiment has a general tubular structure with a lumen 319 and central entry port 316 and two peripheral ports 318A, 318B.
  • the central port may by one embodiment serve for the introduction of a medicament to be delivered into the middle ear through ports 318A, 318B.
  • the device of such a configuration may serve to drain excess fluid from the middle ear, passing through ports 318A, 318B, through lumen 319 and then out of port 316.
  • Fig. 4 is a schematic view of a peripheral segment, according to another embodiment, deployed in cavity 428, for example, the Eustachian tube, where the end portion is configured as a unidirectional valve 422 permitting flow of fluid 426 along the cavity in only one direction.
  • the unidirectional valve effect may be achieved either by the end portion alone or in a combination effect achieved by association of the end portion and the wall of the cavity and may depend on the viscosity of the fluid and on cavity wall flexibility.
  • Fig. 5 shows an embodiment of a device of this disclosure that has a similar configuration to that shown in Fig. 1 with the difference being the inclusion of a weight 530 fixed at the central segment about the midline. This weight adds to augment the natural vibration, as explained above.
  • Fig. 6 shows a schematic illustration of another embodiment of a medical device 600, in which piezoelectric elements 632 are placed along the elongated member 602. The piezoelectric elements 632 may react to external electric potential (which may be imparted by a separate device outside the skull), its activation inducing bending or vibrations of member 602.
  • the peripheral segments 604, 606 comprise sensors or transducers 634.
  • the sensors and transducers can be for example: RF transducers to aid tissue recovery, sound speakers (e.g. piezoelectric) to re-generate sound waves to a patient whose middle-ear does not function well, camera for transmitting images or any other sensor for providing data related to the cavity or device state.
  • Figs. 7A and 7B are schematic views of a peripheral segment 704 of a device, according to yet another embodiment, showing collapsible/expandable structure configuration.
  • the peripheral segment 704 has a plurality of pins 735 that are articulated to the peripheral segment 704, e.g. by a hinge 736.
  • the pins 735 pivotally displace in the general radial direction to their open, expanded position thus temporarily increasing the effective diameter of the peripheral segment 704, represented by circular dotted line 738.
  • the opening may be a one-time event or, alternatively, the array of pins may be switched continuously or intermittently between their collapsed and expanded states.
  • the peripheral segment 704 may have two or more arrays of expandable pins, of the kind shown in Figs. 7A-7B, scattered there along.
  • the actuation of all such arrays may be all simultaneous or not; for example the different arrays may be actuated periodically to jointly define a propagating spatial wave which mimics peristaltic motion to assist fluid flow along the cavity.
  • Peristaltic wave motion direction can be from nasopharynx to middle ear or in the opposite direction. Switching of the pins between their collapsed and expanded states may be done in a variety of mechanical means known per se.
  • Figs. 9A-9B illustrate an embodiment of the device of the present disclosure where the two peripheral segments are coupled to a connector 950 in a releasable manner. While deployed, the device is confined within the Eustachian Tubes as exemplified in Figs. 9A-9B. In other words, even in the extreme case where the device is displaced to one side of the skull and its tip reaches the edge of the Eustachian Tube (namely, the Isthmus), as seen in Fig 9B, it is still safely secured and confined within the two Eustachian Tubes without the risk of falling into the trachea or the lungs in any orientation of the body.
  • the dimensions of the device should be guided by those of the Eustachian Tube; namely, the length of the device is longer than the gap between the two Eustachian Tubes and should occupy at least half of the Eustachian Tube length on each side (R>D).
  • the peripheral segments can be released from the connector 950, e.g. by an actuator, such that the device can be removed safely from the tubes.
  • Figs. 10A-10D show a device according to an embodiment of this disclosure that can be induced into oscillations (either by the subject's motion, by the flow of air while inhaling/exhaling, by an external induction, etc.).
  • the oscillations cause a periodical dilation of the Eustachian Tubes, as exemplified in Figs. 10A to 10D, whereby the opening of the tube increases from an initial width W1 (Figs. 10A and 10C) to W2 (Figs. 10B and 10D)
  • body cavities for which device of different embodiments of this disclosure may be used include the uterus where the first end of the device may be inserted into one fallopian tube and the second end into the other fallopian tube on the other side.
  • a device may comprise a tube with a proximal end in the vagina, permitting a medical practitioner to inject substances that should reach the fallopian tubes or the ovaries.
  • the elongated member 1102 of the device 1100 includes markings 1155A and 1155B at the left and right side of the elongated member 1102, respectively.
  • the markings 1155A, 1155B indicate the length from a mid-portion of the elongated member defined on axis X towards first and second ends 1157A, 1157B of the elongated member 1102, respectively.
  • each of the markings can carry a different color, indicating a different length along the elongated member 1102.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Acoustics & Sound (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)

Abstract

La présente divulgation concerne un dispositif médical (100) comportant des parties qui sont conçues pour être ajustées et retenues simultanément dans deux cavités sur des côtés opposés du corps d'un sujet, par exemple la trompe d'Eustache ou les trompes de Fallope. Le dispositif (100) peut comprendre un élément allongé (102) constitué d'un segment central (103) et de premier et second segments périphériques (104, 106) s'étendant à partir de celui-ci. Les segments diffèrent en termes de fonction prévue et positionnement éventuel in situ : les deux segments périphériques (104, 106) étant destinés à être insérés et positionnés dans les deux cavités pour exercer leur fonction à l'intérieur desdites cavités. Le segment central (103) sert de liaison entre deux segments périphériques et peut également être utilisé pour certaines autres fonctions par sa position. L'élément allongé peut avoir des propriétés élastiques.
PCT/IL2019/050004 2018-01-02 2019-01-02 Dispositif destiné à être déployé et retenu dans deux cavités opposées WO2019135220A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201980014963.8A CN111867533B (zh) 2018-01-02 2019-01-02 用于在两个相对腔室中展开及保持的装置
EP19702311.2A EP3735210A1 (fr) 2018-01-02 2019-01-02 Dispositif destiné à être déployé et retenu dans deux cavités opposées
AU2019205139A AU2019205139A1 (en) 2018-01-02 2019-01-02 A device to be deployed and retained in two opposite cavities
US15/733,338 US11826233B2 (en) 2018-01-02 2019-01-02 Device to be deployed and retained in two opposite cavities
CA3085372A CA3085372A1 (fr) 2018-01-02 2019-01-02 Dispositif destine a etre deploye et retenu dans deux cavites opposees

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL256701 2018-01-02
IL256701A IL256701A (en) 2018-01-02 2018-01-02 A device inserted into two opposite cavities and held in them

Publications (1)

Publication Number Publication Date
WO2019135220A1 true WO2019135220A1 (fr) 2019-07-11

Family

ID=61273988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2019/050004 WO2019135220A1 (fr) 2018-01-02 2019-01-02 Dispositif destiné à être déployé et retenu dans deux cavités opposées

Country Status (7)

Country Link
US (1) US11826233B2 (fr)
EP (1) EP3735210A1 (fr)
CN (1) CN111867533B (fr)
AU (1) AU2019205139A1 (fr)
CA (1) CA3085372A1 (fr)
IL (1) IL256701A (fr)
WO (1) WO2019135220A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061255A (en) * 1985-10-15 1991-10-29 Albert Greenfeld Exterior antimigration refinements for self-cleaning indwelling therapeutic articles
US20050000520A1 (en) * 2003-04-25 2005-01-06 Shlomo Silman Apparatus for treatment of middle ear fluid in the ears of infants and toddlers
WO2007100790A2 (fr) 2006-02-27 2007-09-07 Ahm Technologies, Inc. Dispositif et procede pour trompe d'eustache
WO2007111636A2 (fr) 2005-09-23 2007-10-04 Acclarent, Inc. Dispositifs et procedes pour liberer des substances therapeutiques pour le traitement de la sinusite et d'autres troubles
WO2008045242A2 (fr) 2006-10-04 2008-04-17 Acclarent, Inc. Dispositifs et procédés d'implantation pour traiter une sinusite et d'autres troubles
WO2009001358A2 (fr) 2007-06-26 2008-12-31 Galit Avior Dispositif de trompe auditive
DE102009042249A1 (de) * 2009-09-22 2011-05-05 Universität Rostock Medizinisches Implantat zur Belüftung des Mittelohres
DE102012218164A1 (de) * 2012-10-04 2014-06-12 Universität Rostock Verfahren und System zur Belüftung des Mittelohrs
US20150075536A1 (en) * 2007-03-19 2015-03-19 Hologic, Inc. Methods and apparatus for occlusion of body lumens

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510152C2 (sv) * 1996-09-02 1999-04-26 Nobel Biocare Ab Anordning för ventilation av mellanörat
CN2472693Y (zh) * 2001-03-28 2002-01-23 中国人民解放军第二军医大学 咽鼓管中耳腔注射导管
US6589286B1 (en) * 2001-09-12 2003-07-08 Jason Litner Eustachian tube stent
CN2551265Y (zh) * 2002-06-18 2003-05-21 陈文文 一种新型钛镍合金咽鼓管支架
US8181653B2 (en) 2005-02-15 2012-05-22 Yale University Intrauterine fallopian tube occlusion device
US8161971B2 (en) * 2006-08-04 2012-04-24 Ric Investments, Llc Nasal and oral patient interface
US10206821B2 (en) * 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
US20130253387A1 (en) 2012-03-08 2013-09-26 Sonitec, LLC Vibratory energy systems and methods for occluded body cavities
US9510976B2 (en) * 2014-04-29 2016-12-06 Abbott Cardiovascular Systems Inc. Devices and methods for treatment of the Eustachian tube and sinus cavity
EP3422965B1 (fr) * 2016-03-04 2019-12-11 Aerin Medical, Inc. Dispositif pour modification de la trompe d'eustache

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061255A (en) * 1985-10-15 1991-10-29 Albert Greenfeld Exterior antimigration refinements for self-cleaning indwelling therapeutic articles
US20050000520A1 (en) * 2003-04-25 2005-01-06 Shlomo Silman Apparatus for treatment of middle ear fluid in the ears of infants and toddlers
WO2007111636A2 (fr) 2005-09-23 2007-10-04 Acclarent, Inc. Dispositifs et procedes pour liberer des substances therapeutiques pour le traitement de la sinusite et d'autres troubles
WO2007100790A2 (fr) 2006-02-27 2007-09-07 Ahm Technologies, Inc. Dispositif et procede pour trompe d'eustache
WO2008045242A2 (fr) 2006-10-04 2008-04-17 Acclarent, Inc. Dispositifs et procédés d'implantation pour traiter une sinusite et d'autres troubles
US20150075536A1 (en) * 2007-03-19 2015-03-19 Hologic, Inc. Methods and apparatus for occlusion of body lumens
WO2009001358A2 (fr) 2007-06-26 2008-12-31 Galit Avior Dispositif de trompe auditive
DE102009042249A1 (de) * 2009-09-22 2011-05-05 Universität Rostock Medizinisches Implantat zur Belüftung des Mittelohres
DE102012218164A1 (de) * 2012-10-04 2014-06-12 Universität Rostock Verfahren und System zur Belüftung des Mittelohrs

Also Published As

Publication number Publication date
CN111867533A (zh) 2020-10-30
EP3735210A1 (fr) 2020-11-11
IL256701A (en) 2018-02-28
US20210113382A1 (en) 2021-04-22
CN111867533B (zh) 2022-09-13
AU2019205139A1 (en) 2020-07-23
US11826233B2 (en) 2023-11-28
CA3085372A1 (fr) 2019-07-11

Similar Documents

Publication Publication Date Title
US10166133B2 (en) Device for intermittently obstructing a gastric opening
US20100121371A1 (en) Non-endoscopic insertion and removal of a device
JP5276117B2 (ja) 胃内袋給送装置
US10022262B2 (en) Palate retainer with attached nasopharyngeal airway extender for use in the treatment of obstructive sleep apnea
US20050267489A1 (en) Retrieval device
JP2007500555A5 (fr)
JP7250460B2 (ja) 耳管開放症のステント
EP2303390A1 (fr) Dispositifs a ancrage tissulaire
US20170049981A1 (en) Nasopharyngeal device for obstructive sleep apnea syndrome
US10368973B2 (en) Devices and methods for gastrointestinal bypass
US11826233B2 (en) Device to be deployed and retained in two opposite cavities
ATE504242T1 (de) System zur intravascularen implantation
EP3598958B1 (fr) Appareil d'ancrage d'un implant gastro-intestinal
EP3490427B1 (fr) Dispositifs de laryngoscopie
US11033419B2 (en) Medical device for performing ileostomies and/or jejunostomies
KR20180128842A (ko) 경비담관 배액관의 구강-비강 위치변경 장치
WO2018063183A1 (fr) Dispositif nasopharyngé pour le syndrome d'apnée obstructive du sommeil
AU2013206337B2 (en) Device for intermittently obstructing a gastric opening and method of use
JP2022551183A (ja) 胎児摘出装置
JP2009142692A (ja) 経鼻挿入式内視鏡用着鼻保護具

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19702311

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3085372

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 3085372

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019205139

Country of ref document: AU

Date of ref document: 20190102

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2019702311

Country of ref document: EP

Effective date: 20200803